Shanghai HeartCare H1 FY26 profit climbs 18.5% to RMB 60.37 million; revenue rises 56.9% to RMB 291.03 millionPUBT·Aug 31 at 09:02 AM06609+4.63%
Unbundling and Moving Up the Value Chain: A Structural View on HK's Long TailGlobal Report·Aug 25 at 11:33 AM09959+1.15%00799+0.32%
Shifting Gears: How Traditional Heavyweights and Green Pioneers Are Navigating a Transitioning EconomyGlobal Report·Aug 25 at 09:20 AM01354-2.26%01905+5.10%
Shanghai HeartCare Seeks Shareholder Approval for Sci-Tech Board A-Share IssuanceTip Ranks·Aug 14 at 03:07 PM06609+4.63%
Shanghai HeartCare proposes bylaw amendments ahead of planned Shanghai STAR listingPUBT·Aug 14 at 02:50 PM06609+4.63%
The Filter of Capital and Value Chain Realignment: Hong Kong's Market Bifurcation in 2026Global Report·Aug 11 at 09:43 AM01811+0.69%06636-0.39%
Mid-Year Reality Check: Earnings Surprises and Aerospace Pivots in Hong KongGlobal Report·Jul 29 at 09:18 AM01070+1.26%06609+4.63%
The Great Reallocation: From Physical Moats to AI Marginal Cost RevolutionsGlobal Report·Jul 28 at 09:12 AM02099+2.03%01770-1.93%
Shanghai HeartCare Signals Strong Interim Profit and Revenue SurgeTip Ranks·Jul 21 at 01:09 PM06609+4.63%
Shanghai HeartCare Medical Tech files HKEX next-day disclosure return, issues 1 million new shares at HKD 45 eachPUBT·Jun 29 at 02:21 PM06609+4.63%
Shanghai HeartCare amends 2025 H-share incentive scheme vesting schedulePUBT·Jun 29 at 02:17 PM06609+4.63%
Shanghai HeartCare launches H-share buyback of up to HKD 100 millionPUBT·Jun 29 at 02:14 PM06609+4.63%
Shanghai HeartCare completes private placement of 1,000,000 domestic shares at HK$ 45 eachPUBT·Jun 29 at 02:10 PM06609+4.63%